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Abstract
Background Disparities in adult morbidity and mortality may be rooted in patterns of biological dysfunction in early life.
We sought to examine the association between pathogen burden and a cumulative deficits index (CDI), conceptualized
as a pre-clinical marker of an unhealthy biomarker profile, specifically focusing on patterns across levels of social
disadvantage.
Methods Using the data from the National Health and Nutrition Examination Survey 2003–2004 wave (aged 20–
49 years), we examined the association of pathogen burden, composed of seven pathogens, with the CDI. The CDI
comprised 28 biomarkers corresponding to available clinical laboratory measures. Models were stratified by race/
ethnicity and education level.
Results The CDI ranged from 0.04 to 0.78. Nearly half of Blacks were classified in the high burden pathogen class
compared with 8% of Whites. Among both Mexican Americans and other Hispanic groups, the largest proportion of
individuals were classified in the common pathogens class. Among educational classes, 19% of those with less than a
high school education were classified in the high burden class compared with 7% of those with at least a college
education. Blacks in the high burden pathogen class had a CDI 0.05 greater than those in the low burden class
(P < 0.05). Whites in the high burden class had a CDI only 0.03 greater than those in the low burden class (P < 0.01).
Discussion Our findings suggest there are significant social disparities in the distribution of pathogen burden across race/
ethnic groups, and the effects of pathogen burden may be more significant for socially disadvantaged individuals.
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Introduction
Inequalities in age-related declines and disease are well docu-
mented [1–3]. Age-related disease development is likely the
result of accelerated wear and tear of multiple biological sys-
tems, much of which precedes the development of clinical
disease. Indeed, the growing body of research in this area
suggests that the pace of aging itself is unequally distributed
in the population and that divergence in the pace of aging
likely occurs early in the life course [4]. One potential mech-
anism driving the heterogeneity in the pace of aging is life
course social disadvantage.
Social disadvantage is a broad term used to describe
multiple aspects of inequality that an individual may ex-
perience that both shape access to resources and result in
increased experiences of stress. These inequalities may be
linked to features of an individuals’ social identity (e.g.,
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minority race/ethnicity, nativity status) and/or to an indi-
vidual’s social environment (e.g., socioeconomic status
(SES), neighborhoods) [2, 5–7]. For example, those with
lower education are more likely to experience increased
social disadvantage through limited access to resources
including neighborhood environments, health care, and
occupational choices. Those of minority race/ethnicity
status may also more likely to experience greater social
disadvantage through a variety of pathways including ex-
periences of discrimination interpersonally, institutionally,
and societally.
Social disadvantage may impact biological processes of
aging through several mechanisms. First, socially disadvan-
taged individuals may be more exposed to risk factors that
lead to disease development. For example, individuals of low-
er SES are more likely to be exposed to air pollutants with
known pathogenic effects (e.g., sulfur oxides, fine particu-
lates, ozone) [8, 9]. Individuals of low SES are also more
likely to live in disadvantaged neighborhoods with increased
exposure to crime, unhealthy food environments, increased
exposure to infections, and less access to outdoor space [8].
The stress process is a potential second mechanism operat-
ing in tandem with the previous pathway based on exposure.
For many individuals, sustained social disadvantage results in
prolonged exposure to stress, with a corresponding cascade of
biological consequences. For example, the concept of
allostatic load was coined to describe the wear and tear to
several biological systems with repeated allostatic responses
during periods of stress [10]. In their 2006 study, Geronimus
et al. [11] using allostatic load, based on physiological bio-
markers linked to stress, found that Blacks have higher
allostatic load scores than their White peers throughout mid-
life. Using another measure of biological deterioration associ-
ated with stress, telomere length, Needham et al. [12] found
evidence to suggest that individuals with less than a high
school education had significantly shorter telomeres than in-
dividuals with a college education. Findings such as these
point to an underlying biological vulnerability produced by
social disadvantage. The biological vulnerability produced
by chronic stress may also modify the effects of the aforemen-
tioned risk factors to which one is exposed. Socially disadvan-
taged individuals are therefore more likely to be exposed to
risk factors for disease and have an inhibited ability to mitigate
the effects of such exposures.
Our previous study focused on the development of the two
measurements that could improve our understanding of bio-
logical pathways leading to an altered biomarker profile using
data from the National Health and Nutrition Examination
Survey (NHANES) [13]. The cumulative deficits index
(CDI) is a summary measure incorporating data from 28 bio-
markers that are commonly collected in standard laboratory
biochemistry profiles (e.g., triglycerides, iron, sodium, etc.).
Following previous work using this composite marker, we
conceptualized the CDI as an indicator of an altered physio-
logical profile on several important clinical indicators of over-
all health in human populations [13, 14]. Next, there is a body
of research suggesting that infection with multiple, persistent
pathogens can have a cumulative effect on health, because
many of these persistent pathogens are lifelong, elicit an im-
mune response, and stimulate circulation of inflammatory
molecules [15–19]. Thus, following previous research, we
developed a measure of overall pathogen burden intended to
proxy the total load of persistent infections to which an indi-
vidual is exposed.
We found significant differences in the distribution of the
CDI by age, sex, race/ethnicity, and education in a relatively
young cohort (20–49 years). We also saw significant associa-
tions with the pathogen burden measure and the CDI. While
the findings from this report suggested underlying disparities
in the distribution of the CDI by social factors, given the focus
of the study on measurement, we were not able to delve into
those disparities more thoroughly. In the current report, we
used the measures of CDI and pathogen burden to do a more
in-depth exploration of racial/ethnic and educational dispar-
ities in biological dysfunction. We hypothesized that individ-
uals experiencing increased social disadvantage may have
higher levels of pathogen burden, and this pathogen burden
will produce worse outcomes on the CDI than individuals
experiencing less social disadvantage.
Methods
Study Sample
The study sample was drawn from the continuous NHANES
collected by the National Center for Health Statistics, 2003–
2004 wave. NHANES is a cross-sectional, nationally repre-
sentative survey of the health and nutritional status of the US
non-institutionalized, civilian population aged 2 months and
older. Details of the sampling strategy for the continuous
NHANES can be found at https://wwwn.cdc.gov/nchs/
nhanes/analyticguidelines.aspx. We chose the 2003–2004
wave as it tested more infections than many other waves,
and importantly included cytomegalovirus (CMV). CMV is
a persistent infection, common in the population and for
which there is a large body of evidence documenting the
health consequences of persistent CMV infection [20–22].
Individuals participating in the NHANES provided infor-
mation on a range of demographic characteristics based on an
in-home interview and physical examination and laboratory
studies performed at the mobile examination center.
Our study sample included 20–49 years old who participat-
ed in all three of the survey, physical examination, and labo-
ratory studies. There were 14,623 participants in the 2003–
2004 wave. Of those, 4980 participants were excluded
because they did not participate in the interview, physical ex-
amination, and laboratory studies in the 2003–2004 wave. An
additional 6934 individuals were excluded for whom there
was not complete pathogen sample information available in
the 2003–2004 wave. The final sample included only those
with complete covariate information (2003–2004 Wave Final
N = 2168).
Laboratory Analyses
NHANES participants provided blood and urine samples as
part of the laboratory component of the survey. These samples
were tested for a standard biochemistry panel of markers such
as albumin, calcium, hemoglobin, iron, etc. These data are
then made publically available from NHANES. The laborato-
ry information used to construct the CDI was based on the
biomarkers assessed from blood serum. Additional details on
the laboratory component of NHANES are provided in the
supplement.
Measures
Construction of the Cumulative Deficits Index
Details regarding the construction of the CDI have been pub-
lished previously (see [13]). Briefly, the CDI is composed of
28 biomarkers that are commonly collected in standard bio-
chemistry panels (see supplementary table 1). Each biomarker
was examined separately and was split into quartiles based on
the distribution of that biomarker. Depending on the specific
biomarker and whether high or low levels indicate dysfunc-
tion, individuals received a score of 1 if they were in the
highest or lowest quartile. The final CDI was the sum of the
score of each biomarker divided by the total number of bio-
markers available for that participant. The CDI was construct-
ed in this way as to detect those individuals at the higher/lower
end of the normal range for each biomarker rather than simply
using values that indicate current clinical dysfunction. Using
this approach allowed us to develop a measure applicable to
relatively younger populations; many of whom are not likely
showing abnormal values for the biomarkers assessed.
An increase in the value of the CDI can be interpreted as an
increase in the number of pre-clinical deficits, or as a proxy for
an altered biomarker profile with implications for future dis-
ease development. The CDI should not be used directly for
clinical practice. Rather, it is a tool for estimating population
levels of biological alterations based on several clinical bio-
markers of health.
Classification of Pathogen Burden
The deleterious effects of persistent pathogens on health
have been well documented [15–17, 23]. Yet, the methods
for appropriately capturing the total burden of these path-
ogens is a topic of continued study. A consistent theme in
this work is the value of measurements that incorporate
both the number of pathogens as well as the combination
of pathogens an individual is infected with [24]. To that
end, we used latent class methods that account for both of
these elements to capture pathogen burden. The pathogen
burden measure compiled data on the following seven
infections: CMV, herpes simplex virus type 1 (HSV-1),
herpes simplex virus type 2 (HSV-2), human papilloma-
virus virus (HPV), syphilis, toxoplasmosis, and human
immunodeficiency virus (HIV). Details on the pathogen
measurements are provided in the supplement.
Using the latent class analyses, we classified individuals
into pathogen burden subgroups. Classification methods are
detailed in the previous manuscript (see [13]; supplementary
tables 2 and 3). We followed the three-step inclusive-analyze
approach proposed by Bray et al. [25] which first classifies
individuals into latent classes and then regresses the outcome
on the latent classes. We used three latent classes of pathogen
burden based on both model fit indices and interpretability.
We then assigned labels to the classes based on our assessment
of their pathogen composition. The Blow burden^ class was
characterized by having lower probabilities of seropositivity
on all pathogens. Alternatively, the Bhigh burden^ class had
higher probabilities of being seropositive to several of the
pathogens tested. Finally, the Bcommon pathogens^ class
was characterized by individuals with higher probabilities of
seropositivity to common pathogens such as CMVand HSV-
1. For statistical modeling, the low burden class was used as
the referent.
Covariates
We controlled for covariates that are likely associated with
either pathogen burden and/or the CDI. Demographic controls
included age and sex. Age was analyzed as a continuous var-
iable in years. Sex was binary coded as male or female. Health
status characteristics included BMI and smoking status. BMI
was examined categorically with those with a BMI less than
18.5 classified as underweight, 18.5–25 classified as normal,
25–30 classified as overweight, and greater than 30 classified
as obese. Smoking status was classified as having ever
smoked versus never smoked. We also used data on the num-
ber of chronic conditions an individual reported to include
chronic disease burden as a covariate.
Analyses were stratified by race/ethnicity and educa-
tion. Race/ethnicity was categorized according to the
NHANES guidelines as non-Hispanic White, non-
Hispanic Black, Mexican American, other Hispanic, and
other race. Education was treated categorically according
to NHANES classifications as less than a high school
education, high school graduate, some college education,
and college graduate and above.
Statistical Analyses
Regression Analyses
Linear regression models were constructed to examine the
association between the latent categories of pathogen bur-
den and the CDI, stratified by race/ethnicity and educa-
tion. The difference in the mean CDI was estimated with
the low burden group as the referent. Our previous work
documents the weaker associations between other metrics
of pathogen burden assessment (single pathogen associa-
tions and a pathogen burden summary score) and the CDI.
Additionally, the results of the full models including race/
ethnicity and education as covariates in the statistical
models are detailed in the previous report.
We then tested two-way interactions between the latent
classes and both race/ethnicity and education. Two sets of
subsequent models were developed: one stratified by race/
ethnicity and the other by educational attainment. For models
stratified by race/ethnicity, models included controls for age,
sex, BMI, smoking, chronic conditions, and education. For
analyses stratified by education, models included controls
for age, sex, BMI, smoking, chronic conditions, and
race/ethnicity.
All regression analyses used appropriate sampling weights
and adjustments to account for the complex survey design
features. A two-side alpha of 0.05 was used to determine
significance in all statistical analyses.




The study sample comprised 2168 individuals aged 20–
49 years old (mean age 34.9 years). The sample was 50%
female and 69% non-Hispanic White. One-quarter of the
study sample had a college education or greater, and 52%
of the sample were classified as never smokers. Over half
of the study population (64%) had a body mass index
(BMI) greater or equal to 25 while one-quarter (25%)
reported having been diagnosed with one or more chronic
conditions (Table 1).
There were seven pathogens tested in the population. Over
half of the study population (60%) were seropositive to HSV-
1; 19%, seropositive to HSV-2; 25%, to HPV; 13%, seropos-
itive to toxoplasmosis; 0.44%, to HIV; 52%, seropositive to
CMV; and 2%, to syphilis.
The Distribution of Latent Classes by Race/Ethnicity
and Education
Latent class analyses were performed to classify individuals
into pathogen burden categories identified in earlier research.
The distribution of latent classes was significantly different
across race/ethnic groups (P < 0.0001). Among non-
Table 1 Population-weighted demographic and pathogen
characteristics of the study population in the National Health and









Non-Hispanic White 1045 (69)
Non-Hispanic Black 500 (12)
Mexican American 471 (10)
Other Hispanic 82 (4)
Other Race 70 (4)
Education
Less than high school 484 (15)
High school graduate 569 (27)
Some college 676 (34)




Body mass index (BMI)
Underweight (less than 18.5) 41 (2)
Normal (≥ 18.5, < 25) 703 (34)
Overweight (≥ 25, < 30) 709 (33)
Obese (≥ 30) 715 (31)
Chronic condition
Any chronic condition 465 (25)
None 1703 (75)
Pathogens seropositivity
Herpes simplex virus type 1 1397 (60)
Herpes simplex virus type 2 472 (19)
Human papillomavirus 542 (25)
Toxoplasmosis 296 (13)
Human immunodeficiency virus 13 (0.44)
Cytomegalovirus 1315 (52)
Syphilis 51 (2)
The chronic condition variable was based on participant report of physi-
cian diagnosis of one of the following conditions: arthritis, congestive
heart failure, coronary heart disease, heart attack, stroke, emphysema,
chronic bronchitis, liver condition, thyroid problem, or cancer
HispanicWhites, 62% were classified in the low burden class,
30% as in the common pathogens class, and 8% in the high
burden class (Fig. 1a). Conversely, among non-Hispanic
Blacks, 25% were classified in the low burden class, 35% in
the common pathogens class, and 40% in the high burden
class. Among both Mexican Americans and other Hispanic
groups, the largest proportion of individuals were classified
in the common pathogens class.
The distribution of pathogen latent classes also differed
significantly across educational categories (P < 0.0001)
(Fig. 1b). As education increased, the proportion of individ-
uals classified in the low burden class increased. Among those
with less than a high school education, 26% of individuals
were classified as low burden compared with 66% of those
with college degrees and above. Conversely, the proportion of
individuals classified in the high burden class was highest
among those with less than a high school education (19%)
compared with those with college degrees and above (7%).
CDI by Levels of Race/Ethnicity and Education
We then examined how the CDI differed by race/ethnicity and
educational levels (Table 2). The mean CDI differed signifi-
cantly by race/ethnicity. Non-Hispanic Whites had the lowest
mean CDI with a value of 0.29, while the other Hispanics
category had the highest CDI of 0.34 (P = 0.01). Those having
a college degree or above had the lowest mean CDI of 0.28,
while those with less than a high school education had a mean
CDI of 0.33 (P < 0.0001). Descriptive statistics of the CDI for
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Fig. 1 a Distribution of the
pathogen latent classes across
levels of race/ethnicity for the
National Health and Nutrition
Examination Survey, 2003–2004
(N = 2168). b Distribution of the
pathogen latent classes across
levels of education for the
National Health and Nutrition
Examination Survey, 2003–2004
(N = 2168)
Table 2 The mean CDI by race/ethnicity and educational levels for the
National Health and Nutrition Examination Survey (N = 2168)
N (%) Mean CDI
Race/ethnicity
Non-Hispanic Whites 1045 (69) 0.29 (0.003)
Non-Hispanic Blacks 500 (12) 0.32 (0.005)
Mexican Americans 471 (10) 0.33 (0.007)
Other Hispanics 82 (4) 0.34 (0.02)
Other 70 (4) 0.32 (0.01)
Education
Less than high school 484 (15) 0.33 (0.006)
High school graduate 569 (27) 0.32 (0.006)
Some college 676 (34) 0.30 (0.005)
College grad and above 439 (25) 0.28 (0.006)
Association Between Race/Ethnicity, Education,
and the CDI
Finally, we tested two-way interactions between the latent
classes and both race/ethnicity and education (supplementary
table 4). Both interaction terms were significant or borderline
significant suggesting differences in the association of patho-
gen burden and the CDI by race/ethnicity and education (P for
race/ethnicity = 0.06; P for education = 0.02). Thus, based on
the statistical results and a priori hypotheses, we stratified the
subsequent statistical models.
Significant associations between the CDI and the pathogen
latent classes were observed for both non-Hispanic Whites
and non-Hispanic Blacks in stratified analyses (Table 3).
Among non-Hispanic Whites, those in the high burden class
had a CDI 0.028 greater than those in the low burden class
(P = 0.05). Among non-Hispanic Blacks, those in the com-
mon pathogens class had a CDI 0.045 greater than those in
the low burden class; those in the high burden class had a CDI
0.049 greater than those in the low burden class (P = 0.01 and
P = 0.01, respectively).
Among educational categories, there were significant
associations between the CDI and the pathogen latent
classes among high school graduates, those with some
college education, and those with a college degree or
higher (Table 4). Among high school graduates, those in
the high burden class had a CDI 0.062 greater than those
in the low burden class (P < 0.001); those in the common
pathogens class had a CDI 0.045 greater than those in the
low burden class (P < 0.01). Among those with some col-
lege education, those in the common pathogens class had
a CDI 0.055 greater than those in the low burden class
(P < 0.0001) while those in the high burden class had a
CDI 0.032 greater than those in the low burden class
(P < 0.05). Among those with college degrees or above,
those in the common pathogens class had a CDI 0.030
greater than those in the low burden class (P = 0.05).
Sensitivity Analyses
In sensitivity analyses, we replicated the main analyses using
the 2009–2010 wave. We found similar gradients in the mean
CDI by race/ethnicity and education. In regression analyses,
we did not observe consistent significant associations between
pathogen burden and the CDI when stratified by race/ethnicity
and education. We believe this is likely due to missing data on
CMV in 2009–2010. Results of these analyses are reported in
the supplementary material (supplementary tables 5 and 6).
Discussion
We applied a cumulative deficits approach to examine the role
of social disadvantage on pathogen burden and multifactor
marker of biological dysfunction labeled the cumulative def-
icits index (CDI). Our study yielded several important insights
critical to understanding the ways in which social disadvan-
tage may impact biological processes across the life course.
First, we found that the CDI and the distribution of the path-
ogen burden latent classes differed significantly by race/
ethnicity and educational level illustrating the underlying so-
cial structure of both pathogen burden and biological dysfunc-
tion. Second, based on the interaction analyses and the subse-
quent stratified models, we found that the effect of being in the
high burden class of pathogen burden was worse for non-
Hispanic (NH) Blacks and those of lower educational status
than for NH Whites and those with a college education.
Together, these findings suggest a social stratification under-
lying both the distribution of pathogen burden and the effects
of pathogen burden on biological dysfunction, as measured by
the CDI.
Persistent viruses, such as those in the herpesvirus family,
are frequently subclinical without signs of severe illness at the
time of infection [26–28]. Infection often occurs early in life
leading to a process of latency and reactivation across the life
Table 3 Results of the regression analysis examining the association between the latent classes of pathogen burden and the cumulative deficits index
stratified by race/ethnicity in the National Health and Nutrition Examination Survey 2003–2004
Non-Hispanic Whites Non-Hispanic Blacks Mexican Americans Other Hispanics Other
Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI
Intercept 0.25** 0.22, 0.27 0.23** 0.17, 0.28 0.20** 0.14, 0.26 0.19* 0.03, 0.35 0.33** 0.24, 0.42
Latent classes
Low burden Ref. Ref. Ref. Ref. Ref.
Common pathogens 0.04** 0.02 0.06 0.05* 0.02, 0.08 0.025 − 0.002, 0.05 − 0.01 − 0.11, 0.09 0.04 − 0.03, 0.11
High burden 0.03* 0.01, 0.05 0.05** 0.01, 0.08 0.008 − 0.04, 0.05 − 0.02 − 0.13, 0.10 0.03 − 0.04, 0.10
Results of the full model controlling for the following covariates: age, sex, BMI, smoking, education, and chronic conditions
*P < 0.05; **P < 0.01
course [29]. Each period of reactivation requires substantial
immune resources to control the infection, effectively acceler-
ating the pace of immunosenescence. This is born out in stud-
ies using various metrics of immunological aging. For exam-
ple, herpesvirus coinfections are associated with significant
declines in leukocyte telomere length prospectively over
3 years [30]. Studies of CMV, specifically, find that nearly
10% of CD4 and CD8 cells are devoted to CMV control
[31–34], effectively aging the immune compartment.
We found that individuals with lower education and indi-
viduals of minority race/ethnicity were more likely to be in the
high pathogen burden class. This is consistent with the grow-
ing body of research documenting the association between
latent viruses and social status. Individuals of low SES have
higher antibody titers to CMV, HSV-1, Helicobacter pylori,
and Chlamydia pneumoniae. Moreover, children with lower
family income and parental education and children ofminority
race/ethnicity have higher levels of infection with pathogens
including Epstein-Barr virus (EBV), H. pylori, CMV, HSV-1,
hepatitis B virus (HBV), and hepatitis Avirus (HAV) [35–37].
Despite the number of studies suggesting an underlying
social stratification process of latent viral infections, few stud-
ies have examined whether the association between social
disadvantage and pathogen burden is consistent across SES
groups of individuals. We found significant interactions be-
tween latent class membership and both race/ethnicity and
education. These findings suggest that individuals experienc-
ing greater social disadvantage were more likely to be in the
high pathogen burden class and that being in the high burden
class was associated with increased deficits for those
individuals.
While the CDI is a not direct measure of clinical disease,
we believe these findings are indeed clinically relevant since
the CDI is composed of markers that are used to indicate the
health of multiple systems in the body. For example, high
triglycerides are related to cardiometabolic health and lower
than normal iron levels can indicate anemia and blood disor-
ders. Based on our index, a change in the detrimental direction
in only one of these markers results in a change in the overall
CDI. Therefore, the CDI provides a broad measure of changes
in clinically relevant biomarkers that are used to navigate and
identify health concerns in populations. For example, among
non-Hispanic Blacks, a change in the CDI of 0.05 is roughly
equivalent to an increase of 1.3 in the number of deficits for an
individual. For a high school graduate, a change of 0.06 is
roughly equivalent to an increase of 1.7 in the number of
deficits. Increases in the number of deficits could then indicate
that an individual has one or more body systems on a trajec-
tory towards clinical dysfunction. In this way, we believe
changes in the CDI are clinically significant because of their
holistic impact on the probability of future disease
development.
While the cross-sectional nature of the data does not allow
for a formal adjudication of causal processes, evidence from
prospective studies suggests that causal mechanisms could be
at work. For example, a number of studies have found pro-
spective evidence linking experiences of stress to subsequent
increases in herpesvirus antibodies [38–44], suggesting that
stress resulting from experiences of racism for racial/ethnic
minorities and/or sustained low SES among those with less
education may directly impact pathogen burden, and ensuing
physiological wear and tear. Additionally, it may be that in-
creased individual-level social disadvantage correlates with
living in physical environments that both increase exposure
to infectious pathogens (i.e., from crowded living conditions),
and experiences of psychosocial stress (i.e., due to increased
neighborhood crime or disorder) [45, 46].
Indeed, the stress literature bears this out. Sustained disad-
vantage has been associated with prolonged activation of the
stress process [47]. Chronic stress is linked with higher levels
of inflammation [48, 49] and diminished immune function
[50, 51]. The seminal studies by Cohen et al. found that those
reporting lower levels of subjective social status fared worse
when exposed to a viral challenge than those of higher social
status [52, 53]. The authors suggest that these findings may be
partially mediated by health behaviors such as sleep duration
Table 4 Results of the regression analysis examining the association between the latent classes of pathogen burden and the cumulative deficits index
stratified by education in the National Health and Nutrition Examination Survey 2003–2004
Less than HS HS grad Some college College graduate
Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI
Intercept 0.27** 0.22, 0.32 0.23** 0.19, 0.27 0.24** 0.19, 0.28 0.25** 0.19, 0.32
Latent classes
Low burden Ref. Ref. Ref. Ref.
Common pathogens 0.01 − 0.03, 0.04 0.05** 0.02, 0.07 0.05** 0.03, 0.07 0.030* 0.0001, 0.06
High burden 0.02 − 0.01, 0.05 0.06** 0.03, 0.09 0.03* 0.01, 0.06 − 0.01 − 0.06, 0.04
Results of the full model controlling for the following covariates: age, sex, BMI, smoking, race/ethnicity, and chronic conditions
*P < 0.05; **P < 0.01
and quality, and other psychological traits serving as buffers
that confer a greater ability to cope with stress. Vis-à-vis these
hypotheses, individuals experiencing sustained social disad-
vantage may have fewer behavioral and psychological re-
sources to cope with stress, and therefore, biological pressures
such as those presented by persistent infections may have
increased biological costs for these individuals.
While we believe this study provides critical insights
into the biology of social disadvantage, it is not without
limitations. First, the data are cross-sectional which
limits our ability to establish a temporal sequence, and
therefore causality. Future studies should investigate
whether pathogen burden predicts increased deficits over
time, and compare these trajectories among race/ethnic
and educational sub-populations. Additionally, the data
used are from 2003 to 2004. However, we do not believe
overall trends in the prevalence of persistent infections or
social disparities have significantly changed in the inter-
vening years, suggesting these trends are generalizable to
current populations. Indeed, evidence from other work in
this area suggests that educational disparities in pathogen
burden are widening (Stebbins, Noppert, Aiello et al.,
unpublished work 2019). Thus, we believe our estimates
of the overall educational and race/ethnic disparities in
pathogen burden may be an underestimate of current
trends.
Our findings point to a strong role of the social environ-
ment in determining the distribution of pathogen burden as
well as overall patterns of biological dysfunction. However,
our ability to capture the social environment was limited by
the data available in the NHANES. Testing of these relation-
ships with datasets that offer more robust assessments of the
social environment may further elucidate the mechanisms at
work.
Finally, the variables used to construct both the CDI and the
pathogen burden measure are not comprehensive. Other bio-
logical markers and infections may be critical to understand-
ing these processes. Future replication studies are critical to
better understand the biological processes at work.
In conclusion, we found evidence that individuals of lower
education and individuals of minority race/ethnicity both had
unhealthier biomarker profiles, as measured by the CDI, and
were more likely to experience higher levels of pathogen bur-
den. Perhaps, more importantly, the effects of high pathogen
burden on biomarker profiles were worse for these groups.
These findings point to underlying social processes that both
put certain groups of individuals at higher risk for exposure to
infections with fewer biological resources to buffer the effects
of such infections. Notably, these findings were observed in a
relatively young cohort before clinical disease typically man-
ifests. Public health interventions that reduce pathogen load
may address overall changes in biological dysfunction, reduc-
ing health disparities in the aging process.
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